StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3053% below fair value
$43.64+0.61 (+1.42%)

Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –

Boston Scientific Adjusted EBITDA (Non-GAAP, $M) by Quarter

Adjusted EBITDA (Non-GAAP, $M) ($M)

Boston Scientific Adjusted EBITDA (Non-GAAP, $M): $1,464M in Q3 2026, down 2.5% from a year earlier.

Latest, Q3 2026
1,464
Period ended Sep 30, 2026
Change on a year earlier
-2.5%
1,502 in Q3 2025
History
18 quarters
Since Q2 2022
Sources
15
Documents cited below

Where the Q3 2026 figure comes from

“Adjusted EBITDA $ 1,558 $ 1,540 $ 1,630 $ 1,464 $ 6,192”

Source: BSX FY2026Q3 Financial & Operational Highlights Presentation ↗

Reported in Quarterly FOH Appendix C (Reconciliation of Debt to Adjusted EBITDA) & Form 10-K/10-Q Note F.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAdjusted EBITDA (Non-GAAP, $M) ($M)Year on yearSource
Q3 2026Sep 30, 20261,464-2.5%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q2 2026Jun 30, 20261,630+9.6%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q1 2026Mar 31, 20261,540+8.0%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q4 2025Dec 31, 20251,558+15.9%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q3 2025Sep 30, 20251,502+23.0%BSX FY2026Q2 Financial & Operational Highlights Presentation ↗
Q2 2025Jun 30, 20251,487+24.3%BSX FY2026Q1 Financial & Operational Highlights Presentation ↗
Q1 2025Mar 31, 20251,426+32.3%BSX FY2025Q4 Financial & Operational Highlights Presentation ↗
Q4 2024Dec 31, 20241,344+25.6%BSX FY2025Q3 Financial & Operational Highlights Presentation ↗
Q3 2024Sep 30, 20241,221+23.2%BSX FY2025Q2 Financial & Operational Highlights Presentation ↗
Q2 2024Jun 30, 20241,196+16.3%BSX FY2025Q1 Financial & Operational Highlights Presentation ↗
Q1 2024Mar 31, 20241,078+16.2%BSX FY2024Q4 Financial & Operational Highlights Presentation ↗
Q4 2023Dec 31, 20231,070+18.9%BSX FY2024Q3 Financial & Operational Highlights Presentation ↗
Q3 2023Sep 30, 2023991+15.0%BSX FY2024Q2 Financial & Operational Highlights Presentation ↗
Q2 2023Jun 30, 20231,028+15.9%BSX FY2024Q1 Financial & Operational Highlights Presentation ↗
Q1 2023Mar 31, 2023928–BSX FY2023Q4 Financial & Operational Highlights Presentation ↗
Q4 2022Dec 31, 2022900–BSX FY2023Q3 Financial & Operational Highlights Presentation ↗

Breakdown

What makes up adjusted EBITDA (Non-GAAP, $M)

Cite this data

StockData. (2026). Boston Scientific Adjusted EBITDA (Non-GAAP, $M) ($M), quarterly Q2 2022–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/lev-adj-ebitda

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?